Chronic obstructive pulmonary disease(COPD)is a common disease that seriously harms human health,and it is also a leading cause of death,with a large number of cases being underdiagnosed.Can COPD screening enable early diagnosis of the disease and improve patient outcomes?In 2022,the U.S.Preventive Services Task Force(USPSTF)updated its"Chronic Obstructive Pulmonary Disease Screening Recommendation Statement"(hereinafter referred to as the"Recommendation")for asymptomatic adults by evaluating the latest research evidence regarding the benefits and harms of COPD screening.Based on limited evidence,the USPSTF issused a'D'statement(there is moderate certainty that the screening has no net benefit)and recommends against COPD screening for asymptomatic adults,which is consistent with the 2016 version.The current article interprets the principles of this Recommendation in the context of Chinese general practice.
万方数据
维普
